Vertex Pharmaceuticals Incorporated logo

Vertex Pharmaceuticals IncorporatedNASDAQ: VRTX

Profile

Sector:

Healthcare

Industry:

Biotechnology

Country:

United States

IPO:

24 July 1991

Next earnings report:

04 November 2024

Last dividends:

N/A

Next dividends:

N/A
$120.79 B
-8%vs. 3y high
99%vs. sector
-vs. 3y high
-vs. sector
-8%vs. 3y high
90%vs. sector
-8%vs. 3y high
77%vs. sector

Price

after hours | Fri, 01 Nov 2024 23:58:23 GMT
$468.00-$6.39(-1.35%)

Dividend

No data over the past 3 years
$2.65 B$2.72 B
$2.65 B-$3.59 B

Analysts recommendations

Institutional Ownership

VRTX Latest News

Vertex Pharmaceuticals (VRTX) Stock Drops Despite Market Gains: Important Facts to Note
zacks.com28 October 2024 Sentiment: NEUTRAL

Vertex Pharmaceuticals (VRTX) finished the most recent trading session at $476.37, which is a decrease of 0.28% compared to the previous day.

The Smartest Growth Stock to Buy With $500 Right Now
fool.com25 October 2024 Sentiment: POSITIVE

This stock may not stay below $500 for much longer.

Investors Heavily Search Vertex Pharmaceuticals Incorporated (VRTX): Here is What You Need to Know
zacks.com22 October 2024 Sentiment: POSITIVE

Users of Zacks.com have been paying a lot of attention to Vertex (VRTX) lately. Therefore, it's important to understand the key information that could influence the stock's future.

Why Vertex Pharmaceuticals (VRTX) Dipped More Than Broader Market Today
zacks.com21 October 2024 Sentiment: NEUTRAL

At the end of the last trading day, Vertex Pharmaceuticals (VRTX) was priced at $478.09, which represents a decrease of 1.02% compared to the day before.

Vertex Pharmaceuticals (VRTX) Ascends But Remains Behind Market: Some Facts to Note
https://www.zacks.com/stock/news/2350280/vertex-pharmaceuticals-vrtx-ascends-but-remains-behind-market-some-facts-to-note?cid=CS-STOCKNEWSAPI-FT-tale_of_the_tape|yseop_template_6v2-235028014 October 2024 Sentiment: POSITIVE

Vertex Pharmaceuticals (VRTX) finished the last trading day at $484.94, which is an increase of 0.67% compared to the day before.

Here is What to Know Beyond Why Vertex Pharmaceuticals Incorporated (VRTX) is a Trending Stock
zacks.com09 October 2024 Sentiment: POSITIVE

Lately, users of Zacks.com have been focusing on Vertex (VRTX). This interest prompts a closer look at what the stock might offer.

Vertex Pharmaceuticals (VRTX) Registers a Bigger Fall Than the Market: Important Facts to Note
zacks.com07 October 2024 Sentiment: NEUTRAL

Vertex Pharmaceuticals (VRTX) finished the last trading session at $448.16, which represents a decrease of 1.57% compared to the previous day's closing price.

Vertex Pharmaceuticals (VRTX) Surpasses Market Returns: Some Facts Worth Knowing
zacks.com30 September 2024 Sentiment: POSITIVE

At the end of the last trading day, Vertex Pharmaceuticals (VRTX) was priced at $465.08, which represents a 0.48% increase compared to the day before.

Wall Street Analysts See Vertex (VRTX) as a Buy: Should You Invest?
zacks.com26 September 2024 Sentiment: POSITIVE

Investors frequently depend on the advice of Wall Street analysts to make choices about buying, selling, or holding stocks. News articles about these analysts from brokerage firms changing their ratings can significantly influence a stock's price.

Is Trending Stock Vertex Pharmaceuticals Incorporated (VRTX) a Buy Now?
zacks.com25 September 2024 Sentiment: POSITIVE

Users of Zacks.com have been paying a lot of attention to Vertex (VRTX) lately. Therefore, it's important to understand the key information that could influence the stock's future.

What type of business is Vertex Pharmaceuticals Incorporated?

Vertex Pharmaceuticals Incorporated is an American biopharmaceutical company headquartered in Boston, Massachusetts, specializing in the development and commercialization of drug therapies for cystic fibrosis (CF) and other serious diseases. It was founded in 1989. Currently, the company's product portfolio includes medications such as SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO. These three drugs combined are approved for the treatment of approximately half of the 75,000 CF patients in North America, Europe, and Australia.

What sector is Vertex Pharmaceuticals Incorporated in?

Vertex Pharmaceuticals Incorporated is in the Healthcare sector

What industry is Vertex Pharmaceuticals Incorporated in?

Vertex Pharmaceuticals Incorporated is in the Biotechnology industry

What country is Vertex Pharmaceuticals Incorporated from?

Vertex Pharmaceuticals Incorporated is headquartered in United States

When did Vertex Pharmaceuticals Incorporated go public?

Vertex Pharmaceuticals Incorporated initial public offering (IPO) was on 24 July 1991

What is Vertex Pharmaceuticals Incorporated website?

https://www.vrtx.com

Is Vertex Pharmaceuticals Incorporated in the S&P 500?

Yes, Vertex Pharmaceuticals Incorporated is included in the S&P 500 index

Is Vertex Pharmaceuticals Incorporated in the NASDAQ 100?

Yes, Vertex Pharmaceuticals Incorporated is included in the NASDAQ 100 index

Is Vertex Pharmaceuticals Incorporated in the Dow Jones?

No, Vertex Pharmaceuticals Incorporated is not included in the Dow Jones index

When was Vertex Pharmaceuticals Incorporated the previous earnings report?

No data

When does Vertex Pharmaceuticals Incorporated earnings report?

The next expected earnings date for Vertex Pharmaceuticals Incorporated is 04 November 2024